Merrion Pharma Files for IPO

Merrion Pharmaceuticals Ltd., a Dublin, Ireland-based developer of oral dosage forms of drugs with poor bioavailability, has filed for a $46 million IPO. It plans to trade on the Nasdaq under ticker symbol MERR, with Punk Ziegel & Co. serving as lead underwriter. Shareholders include European Bioscience Fund, Growcorp Group and Elan Corp.